Judge tosses defamation case brought by Ohio doctor who was acquitted of killing patients
COLUMBUS, Ohio (AP) — A former Ohio doctor who was fired before being found not guilty on murder charges in the deaths of 14 patients lost a defamation lawsuit against his former employers on Monday, after a judge stepped in for a jury on grounds the evidence presented by the defendants was incontrovertible.
Franklin County Judge Stephen McIntosh issued his directed verdict against former doctor William Husel, whose attorneys accused Michigan-based Trinity Health and Mount Carmel Health System in Columbus of orchestrating a campaign to destroy his reputation.
Husel was seeking more than $18 million from the health care companies.
His attorney, David Vermillion, said in a statement that Husel's legal team was disappointed that McIntosh would prevent the jury from making a decision in the case after weeks of evidence and testimony had been presented. He said issuing the directed verdict, a procedural move requested by the hospital, 'effectively silences the voices of those who came seeking justice.'
'This is not the outcome that any reasonable person expected, nor is it one that reflects the strength of the evidence presented,' he said. 'We are evaluating all legal options, including appeal. This case has always been about more than one courtroom or one ruling. It is about truth, accountability, and the right of every individual to defend their name against false and damaging accusations.'
Mount Carmel issued a statement that said simply, 'We are pleased with the judge's decision.'
Mount Carmel Health System fired the doctor in 2018 after it concluded he had ordered excessive painkillers for about three dozen patients who died over several years.
He initially was charged with murder in 25 deaths in one of the biggest cases of its kind ever brought against a U.S. health care professional. Eleven counts were dismissed before trial.
Husel, now 49, maintained he was trying to help patients deal with their pain, sometimes in the last moments of their life, not speed up their deaths. Despite being found not guilty by a jury on murder charges in 2022, he permanently surrendered his medical license.
He filed multiple lawsuits against his former employer, accusing Trinity Health and Mount Carmel of defamation and malicious prosecution.
As part of the defamation lawsuit filed in 2019, Husel's attorneys said Trinity Health repeatedly spread lies and false information to convince the public and law enforcement that Husel was a killer, even though health system officials knew that was not true.
'Obviously, these false allegations destroyed Dr. Husel's life,' the lawsuit said. Husel gave up his medical license because his lawyers said that he knew the damage to his reputation would prevent him from working as a doctor.
In court documents filed two years ago, Husel said he had been unable to find work and was diagnosed with post-traumatic stress disorder and depression.
Trinity Health had asked a judge to toss the lawsuit, but a Franklin County judge ruled there was enough reason to move forward.
Husel, who worked in the intensive care unit, was charged in cases that involved the use of at least 500 micrograms of the powerful painkiller fentanyl. Prosecutors said ordering such dosages for nonsurgical situations indicated an intent to end lives.
His colleagues who administered the medications at Mount Carmel West Hospital in Columbus weren't criminally charged, but the hospital said it fired 23 nurses, pharmacists and managers after its internal investigation and referred various employees to their respective state boards for disciplinary action.
The hospital reached settlements in multiple cases involving relatives of the patients who died.
___
Seewer reported from Toledo.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Winnipeg Free Press
13 hours ago
- Winnipeg Free Press
Second patient death reported with gene therapy for muscular dystrophy
WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy. Sarepta reported the death over the weekend and provided additional details about its response, which includes pausing shipments of the therapy, Elevidys, for older patients who are no longer able to walk. The one-time treatment is approved for children with a genetic variant of Duchenne's muscular dystrophy, which causes weakness, loss of mobility and early death in males. Elevidys is the first gene therapy approved in the U.S. for the rare muscle-wasting condition, but it has faced scrutiny since its accelerated approval in 2023. The second death, like an earlier one reported in March, occurred in a teenage boy who suffered a fatal case of acute liver injury, a known side effect of the therapy. Older patients receive a larger dose of the therapy. Sarepta said it would pause a study in those patients and assemble an expert panel to recommend new safety protocols for taking the drug. Those changes are expected to include increased use of immune-system suppressing drugs, company executives said Monday. The liver injury associated with the therapy is thought to be connected to the immune system's response. Sarepta said it was cooperating with the Food and Drug Administration, which would have to sign off on any changes to the product's use. Elevidys received expedited approval despite concerns from some FDA scientists about its effectiveness in treating Duchenne's. The FDA granted full approval last year and expanded the therapy's use to patients 4 years and older, regardless of whether they are still able to walk. Previously it was only available for younger patients who were still walking. Shares of the Cambridge, Massachusetts-based company fell more than 42% to close at about $21 in trading. Wednesdays Columnist Jen Zoratti looks at what's next in arts, life and pop culture. Wall Street analysts speculated that FDA officials, including new vaccine chief Dr. Vinay Prasad, might impose more restrictions on the drug or even block its use. Prasad has been highly critical of the therapy since its approval under the agency's previous leadership. 'Now with two deaths reported in this segment of the market, it seems incrementally more possible that the FDA could step in and remove the therapy from the market in non-ambulatory patients,' said Leerink Partners analyst Joseph Schwartz, in a Sunday research note. Elevidys uses a disabled virus to insert a replacement gene for producing dystrophin into patient cells. It costs $3.2 million for a one-time infusion. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Winnipeg Free Press
13 hours ago
- Winnipeg Free Press
Judge tosses defamation case brought by Ohio doctor who was acquitted of killing patients
COLUMBUS, Ohio (AP) — A former Ohio doctor who was fired before being found not guilty on murder charges in the deaths of 14 patients lost a defamation lawsuit against his former employers on Monday, after a judge stepped in for a jury on grounds the evidence presented by the defendants was incontrovertible. Franklin County Judge Stephen McIntosh issued his directed verdict against former doctor William Husel, whose attorneys accused Michigan-based Trinity Health and Mount Carmel Health System in Columbus of orchestrating a campaign to destroy his reputation. Husel was seeking more than $18 million from the health care companies. His attorney, David Vermillion, said in a statement that Husel's legal team was disappointed that McIntosh would prevent the jury from making a decision in the case after weeks of evidence and testimony had been presented. He said issuing the directed verdict, a procedural move requested by the hospital, 'effectively silences the voices of those who came seeking justice.' 'This is not the outcome that any reasonable person expected, nor is it one that reflects the strength of the evidence presented,' he said. 'We are evaluating all legal options, including appeal. This case has always been about more than one courtroom or one ruling. It is about truth, accountability, and the right of every individual to defend their name against false and damaging accusations.' Mount Carmel issued a statement that said simply, 'We are pleased with the judge's decision.' Mount Carmel Health System fired the doctor in 2018 after it concluded he had ordered excessive painkillers for about three dozen patients who died over several years. He initially was charged with murder in 25 deaths in one of the biggest cases of its kind ever brought against a U.S. health care professional. Eleven counts were dismissed before trial. Husel, now 49, maintained he was trying to help patients deal with their pain, sometimes in the last moments of their life, not speed up their deaths. Despite being found not guilty by a jury on murder charges in 2022, he permanently surrendered his medical license. He filed multiple lawsuits against his former employer, accusing Trinity Health and Mount Carmel of defamation and malicious prosecution. As part of the defamation lawsuit filed in 2019, Husel's attorneys said Trinity Health repeatedly spread lies and false information to convince the public and law enforcement that Husel was a killer, even though health system officials knew that was not true. 'Obviously, these false allegations destroyed Dr. Husel's life,' the lawsuit said. Husel gave up his medical license because his lawyers said that he knew the damage to his reputation would prevent him from working as a doctor. In court documents filed two years ago, Husel said he had been unable to find work and was diagnosed with post-traumatic stress disorder and depression. Trinity Health had asked a judge to toss the lawsuit, but a Franklin County judge ruled there was enough reason to move forward. Husel, who worked in the intensive care unit, was charged in cases that involved the use of at least 500 micrograms of the powerful painkiller fentanyl. Prosecutors said ordering such dosages for nonsurgical situations indicated an intent to end lives. His colleagues who administered the medications at Mount Carmel West Hospital in Columbus weren't criminally charged, but the hospital said it fired 23 nurses, pharmacists and managers after its internal investigation and referred various employees to their respective state boards for disciplinary action. The hospital reached settlements in multiple cases involving relatives of the patients who died. ___ Seewer reported from Toledo.
Ottawa Citizen
4 days ago
- Ottawa Citizen
Ottawa's Best Theratronics misses nuclear decommissioning guarantee deadline
A Kanata company that produces nuclear medical equipment has failed to meet a June 9 deadline set by the Canada's nuclear safety watchdog. Article content Best Theratronics Ltd. manufactures external beam therapy units, blood irradiators, and cyclotrons for hospitals and medical research centres outside Canada. It's part of the Virginia-based TeamBest Global Companies empire headed by Krishnan Suthanthiran, who purchased the company from MDS Nordion in 2007 for a reported $15 million. Article content Article content Article content Last November, Best Theratronics was ordered to provide a $1.8-million financial guarantee to cover the costs of decommissioning the plant on March Road, should that be necessary, by the Canadian Nuclear Safety Commission (CNSC). Article content Article content Given that the deadline has passed, 'CNSC staff will be contacting Best Theratronics to determine the next steps,' said the commission, which regulates nuclear energy, facilities and materials. Article content 'The financial order is still in place and Best Theratronics has not yet fulfilled the conditions of the order.' Article content Best Theratronics is required to re-establish an overall financial guarantee of $1.8 million acceptable to the commission, which is calculated based on the estimated costs of decommissioning, said CNSC in a statement. Article content Article content 'As Canada's nuclear regulator, our rigorous oversight of this facility is ongoing, and we continue to monitor Best Theratronics Ltd. and all nuclear licensees for regular compliance to ensure the safety of workers, the public and the environment.' Article content The financial guarantee is a condition of Best Theratronics' operating licence. According to a CNSC decision, Best Theratronics had failed to maintain the financial guarantee, gave inaccurate reports to the CNSC about the validity of its financial guarantee and was inattentive to updating its preliminary decommissioning plan. That was cause for 'significant concern,' said the decision, signed by CNSC president Pierre Tremblay. Article content Under the CNSB order, among other conditions, Best Theratronics can't operate a cyclotron or possess nuclear substances for manufacturing radiation devices and radioactive source teletherapy machines. It also can't possess a radioactive source teletherapy machine for the purposes of developing and testing radioactive source teletherapy machines.
